NOV 11, 2021 7:00 AM PST

Some Patients Left Vulnerable to COVID Even After Getting Vaccinated

WRITTEN BY: Tara Fernandes

Global vaccination efforts continue in the backdrop of the ongoing pandemic. However, new studies demonstrate how several factors strongly influence the extent of immune protection offered by vaccines. Among them are the individual’s underlying health status and the medications they are currently taking.

study presented at the American College of Rheumatology’s annual meeting provides evidence that patients taking immunosuppressive therapies to treat rheumatoid arthritis are more susceptible to COVID infections, even if they are vaccinated.

Interestingly, the study showed that even patients on potent immunosuppressants (administered to weaken the immune system to reduce the impact of autoimmune diseases on the body) could mount antibody responses against SARS-CoV-2. After getting their shots, the researchers found that nearly 90 percent of the study participants on a glucocorticoid or B-cell depleting therapy produced antibodies against the coronavirus.

However, what was eye-opening for the researchers was that patients on immunosuppressants produced about three times lower antibody levels than those not taking these drugs. 

The Washington University School of Medicine St. Louis team found that B-cell depleting agents, glucocorticoids, and JAK inhibitors were among the medications most likely to inhibit antibody responses. Their analyses revealed that B-cell depleting treatments were the worst, resulting in a whopping 36-fold reduction in humoral responses. 

“These results demonstrate that the risk of suboptimal antibody responses is not uniform across rheumatic disease patients on immunosuppression, and certain populations are at much higher risk of poor or absent responses,” said one of the study leads, Alfred Kim. 

These data illustrate the importance of helping these vulnerable patients achieve more robust immune protection against the coronavirus. For example, they might pause their immunosuppression medicines around the time of vaccinations or receive additional vaccination doses to boost protection.

About the Author
PhD
Interested in health technology and innovation.
You May Also Like
JUN 28, 2022
Immunology
How the Thymus Trains the Immune System
JUN 28, 2022
How the Thymus Trains the Immune System
For centuries, the thymus was dismissed as a vestigial organ. But in the 60s, researchers suggested that it was actually ...
JUL 01, 2022
Coronavirus
Nanobodies Could Protect Us From Every Variant
JUL 01, 2022
Nanobodies Could Protect Us From Every Variant
Immune reactive molecules called nanobodies, which are based on molecules found in llamas could offer robust protection ...
JUL 11, 2022
Immunology
Inflammation in the Gut Can Lead to Skin Disorders
JUL 11, 2022
Inflammation in the Gut Can Lead to Skin Disorders
New research has suggested that inflammation in the gut can reach far beyond the digestive system to affect other areas, ...
AUG 21, 2022
Cancer
The Legacy of Lady Mary Wortley Montagu
AUG 21, 2022
The Legacy of Lady Mary Wortley Montagu
Today, August 21, marks the 260th anniversary of the passing of a pioneer in the medical field.  In 1762, Lady Mary ...
SEP 08, 2022
Earth & The Environment
Climate Change Could Lead to Obscure Sleep Cycles and Weakened Immune Systems
SEP 08, 2022
Climate Change Could Lead to Obscure Sleep Cycles and Weakened Immune Systems
In a recent study published in Temperature, a researcher from the University of California, Los Angeles (UCLA) discusses ...
SEP 02, 2022
Coronavirus
Omicron-Specific Booster Shots Will be Available Soon
SEP 02, 2022
Omicron-Specific Booster Shots Will be Available Soon
Soon, vaccine booster shots that are specific to the Omicron variant will be available in many countries. The new Omicro ...
Loading Comments...